Back to Search Start Over

Research progress on COX-2/PGE2/EP4 signaling axis in colon cancer

Authors :
ZHENG Lirong
DU Haoyang
ZHANG Ruifen
ZHANG Hairong
BAO Aruhan
YU Lei
CUI Hongwei
Source :
Zhongguo linchuang yanjiu, Vol 36, Iss 9, Pp 1338-1341,1347 (2023)
Publication Year :
2023
Publisher :
The Editorial Department of Chinese Journal of Clinical Research, 2023.

Abstract

The expression of cyclooxygenase 2 (COX-2) was up-regulated and prostaglandin E2 (PGE2) was significantly increased in colon cancer patients. As the main prostaglandin produced by COX-2, PGE2 plays an important role in angiogenesis, survival, invasion and migration of colon cancer cells. The EP4 receptor, as an important transporter of PGE2 signaling, increases the survival and development of colon cancer cells through various mechanisms of overexpression. Signal pathway starting from COX-2, continuing with PGE2 and ending with EP4 can promote the spread and growth of colon cancer. Therefore, targeting the COX-2/PGE2/EP4 axis may be a valuable treatment method for colon cancer. This article outlines the biological activity of COX-2, the mechanism of action of COX-2/PGE2/EP4 as a signal axis in colon cancer, and the research progress of targeted drugs in colon cancer prevention.

Details

Language :
Chinese
ISSN :
16748182
Volume :
36
Issue :
9
Database :
Directory of Open Access Journals
Journal :
Zhongguo linchuang yanjiu
Publication Type :
Academic Journal
Accession number :
edsdoj.bb123b6c8ad843e1ad543faad28d2b41
Document Type :
article
Full Text :
https://doi.org/10.13429/j.cnki.cjcr.2023.09.012